Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 590 across all filing types
Latest filing 2010-04-30 Annual Report
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
Annual Report 2009
Annual Report Classification · 100% confidence The document is an 'Årsredovisning 2009' (Annual Report 2009) for RaySearch. It contains comprehensive financial reporting sections, including a management report (Förvaltningsberättelse), income statements, balance sheets, cash flow statements, and notes. It is clearly the full annual report rather than an announcement or a summary. FY 2009
2010-04-30 Swedish
AGM Information 2010
AGM Information Classification · 99% confidence The document is titled "Kallelse till årsstämma 2010" (Notice of Annual General Meeting 2010) and details the date, location, registration procedures, agenda items (including election of the board, approval of financial statements, and dividend proposals), and proposed resolutions for the upcoming shareholder meeting. This content is characteristic of the official notice sent out prior to an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information).
2010-04-22 Swedish
AGM Information 2010
AGM Information Classification · 100% confidence The document is explicitly titled "Invitation to Annual General Meeting 2010" and details the date, location, procedures for shareholder participation (including voting rights and proxy submission), and the proposed agenda for the meeting. The agenda items cover the election of the Chairman, approval of financial statements (referencing the Annual Report), dividend proposals, and remuneration guidelines. This content perfectly matches the definition of materials shared during an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2010-04-22 English
Regulatory Filings 2010
Regulatory Filings Classification · 98% confidence The document is a press release dated March 17, 2010, announcing that RaySearch Laboratories has received 510(k) clearance from the US FDA for its RayStation planning system. This is a specific, material event announcement concerning regulatory approval and market access in the US. It is not a comprehensive annual report (10-K), an earnings release (ER), a management discussion (MDA), or a general regulatory filing (RNS). Since it announces a specific, non-financial operational milestone (FDA approval), it best fits the category for general regulatory announcements or significant operational news that doesn't fit other specific financial/governance codes. Given the options, 'Regulatory Filings' (RNS) serves as the best general category for significant, non-standard operational announcements that aren't explicitly covered by other codes like ER, IR, or CAP, although it is a very specific type of announcement. However, since it is a formal press release detailing a major operational/regulatory achievement, and there is no specific code for 'Regulatory Approval Announcement', RNS is the most appropriate fallback.
2010-03-17 Swedish
Regulatory Filings 2010
Regulatory Filings Classification · 96% confidence The document is a press release dated March 17, 2010, announcing that RaySearch Laboratories received FDA 510(k) clearance for its RayStation treatment planning system. This is a specific corporate announcement regarding regulatory approval for a product, which is not covered by the standard financial filing codes (10-K, IR, ER, etc.). It details a significant operational/regulatory milestone. Since it is a press release announcing a specific event (FDA clearance) and does not fit into the defined categories like Director's Dealing (DIRS), Capital Change (CAP), or Dividend Notice (DIV), it falls best under the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory announcement, or potentially a general announcement if RNS is reserved strictly for exchange filings. Given the options, RNS serves as the best catch-all for significant, non-financial, non-management-change regulatory news that isn't a core financial report.
2010-03-17 English
Interim / Quarterly Report 2009
Interim / Quarterly Report Classification · 95% confidence The document is a 'Bokslutskommuniké' (Year-end report) for RaySearch Laboratories AB for the period 1 January – 31 December 2009. It contains comprehensive financial statements, including income statements, balance sheet summaries, and detailed management commentary on business performance, product launches, and future outlook. As it covers a full fiscal year but is distinct from a formal 10-K (which is a specific US regulatory filing), it falls under the category of an Interim/Quarterly Report (IR) in the context of international financial reporting, as it provides the substantive financial data and analysis for the period. FY 2009
2010-02-18 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.